Evidence map›Paper›PMID 40040925›Full record

ArticleVirus evolution2025

Recently reported SARS-CoV-2 genomes suggested to be intermediate between the two early main lineages are instead likely derived.

Jonathan E Pekar, Niema Moshiri, Philippe Lemey, Alexander Crits-Christoph, Florence Débarre, Stephen A Goldstein, Zach Hensel, Andrew Rambaut, Michael Worobey, Edward C Holmes and 1 more

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan E PekarInstitute of Ecology and Evolution, University of Edinburgh, Ashworth Laboratories, Charlotte Auerbach Rd, Edinburgh EH9 3FL, United Kingdom.ORCID https://orcid.org/0000-0003-0977-2886
Niema MoshiriDepartment of Computer Science & Engineering, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, KU Leuven, Herestraat 49, Leuven BE-3000, Belgium.ORCID https://orcid.org/0000-0003-2826-5353
Alexander Crits-ChristophIndependent Researcher.
Florence DébarreInstitut d'Écologie et des Sciences de l'Environnement (IEES-Paris, UMR 7618), CNRS, Sorbonne Université, UPEC, IRD, INRAE, Paris, France.ORCID https://orcid.org/0000-0003-2497-833X
Stephen A GoldsteinDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, United States.
Zach HenselInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, Oeiras 2780-157, Portugal.
Andrew RambautInstitute of Ecology and Evolution, University of Edinburgh, Ashworth Laboratories, Charlotte Auerbach Rd, Edinburgh EH9 3FL, United Kingdom.ORCID https://orcid.org/0000-0003-4337-3707
Michael WorobeyDepartment of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ 85721, United States.
Edward C HolmesSchool of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.ORCID https://orcid.org/0000-0001-9596-3552
Joel O WertheimDepartment of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.

Funding

San Diego Biomedical Informatics Education & Research (SABER)T15LM011271 · NLM · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SHAMIM NEMATI · 2012 to 2026
$9.7M
NLM NIH HHS T15 LM011271Wellcome Trust
6 · The paper itself

Abstract

Understanding the genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the outset of the coronavirus disease 2019 pandemic can provide insight into the circumstances leading to its emergence. Early SARS-CoV-2 genomic diversity has been classified into two distinct viral lineages, denoted "A" and "B," which we hypothesized were separately introduced into humans. Recently published data contain two genomes with a haplotype suggested to be an evolutionary intermediate to these two lineages, known as "T/T." We used a phylodynamic approach to analyze SARS-CoV-2 genomes from early 2020 to determine whether these two T/T genomes represent an evolutionarily intermediate haplotype between lineages A and B, or if they are a later descendent of either of these two lineages. We find that these two recently published T/T genomes do not represent an evolutionarily intermediate haplotype and were, instead, derived from either lineage A or lineage B. However, we cannot conclusively determine from which lineage they were derived. After including additional data from the start of the pandemic, including these two T/T genomes, we again find a discrepancy in the molecular clock when inferring the ancestral haplotype of SARS-CoV-2, corroborating existing evidence for the separate introductions of SARS-CoV-2 lineages A and B into the human population in late 2019.

Indexed as

molecular clockSARS-CoV-2virus evolution

Identifiers

PMID40040925
PMCPMC11878783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.